United States

ENDO 2021

New Genetic Causes of Congenital Hypothyroidism

Welcome to **ENDO** - the place where leading experts, researchers, and the most respected clinicians in the field come together to share the latest findings in hormone science and discuss breakthroughs in clinical care.

**Endocrine Society** is a global community of physicians and scientists dedicated to accelerating scientific breakthroughs and improving patient health and well being.
<br><br>
For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. **[Read about our history](https://www.endocrine.org/our-community/advancing-endocrinology-and-public-health/history)** and how we continue to serve the endocrine community.

ENDO 2020

ENDO is the place where leading experts, researchers, and the most respected clinicians in the field come together to share the latest findings in hormone science and discuss breakthroughs in clinical care.

technical paper

ENDO is the leading meeting for endocrinology research and clinical care worldwide. 

Protein Substrate for Thyroid Hormone Synthesis

Endoplasmic Reticulum Stress and Thyroid Hormone Signaling

Pediatric Bone Fragility: When to Worry and What to Do?

One Size Doesn't Fit All: How Direct and Indirect Mineralocorticoid Actions Control Distal Nephron Sodium Transport

Glucocorticoid Metabolism in Salt-Induced Hypertension

Mechanisms of Fructose Mediated Hypertension: Sodium, RAS, and Sympathetic Regulation

ß Cells in Type 1 Diabetes - Sleeping or Dead

Preserving ß-Cell Function: Immunotherapies

Strategies to Preserve Residual Beta Cells in Type 1 Diabetes

Membrane Androgen Receptors in Neurodegeneration

https://d3smihljt9218e.cloudfront.net/transcript/25917/subtitle/dcdb93b2bf0f2c23f14a39daad53f9cc.vtt

English (automatic)

Premium content

New Genetic Causes of Congenital Hypothyroidism

Downloads

Next from ENDO 2021

Protein Substrate for Thyroid Hormone Synthesis

Similar lecture

Efficacy and Safety of Higher Dulaglutide Doses (3.0 MG and 4.5 MG) When Added to Metformin in Patients With Type 2 Diabetes: A Phase 3, Randomized, Double-Blind, Parallel ARM Study (Award-11)

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES